← Leaderboards
Christian Wolf
Georgetown University
$3,500,741
Attributed
$3,500,741
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $458.7K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,500,741 · 2
By mechanism
R01$1,856,584 · 1
R15$1,644,157 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPathway InteractionsReactionDrug DiscoveryDimerExhibitsStructurePharmacologyComplexSynthesis ChemistryChemistryPharmacophoreBaseLaboratoriesCollaborationsAntimalarialsDesignAnti-Malarial Drug ResistanceAcridinesCombined Modality TherapyData AnalysesBiochemistryAminoquinolinesBinding (Molecular Function)
Grant awards (9)
Asymmetric Catalysis and Selective C-F Bond Functionalization with Organofluorines$458,705
R15 · FY2023 · GM · contact PI
Selective C-F Bond Functionalization and Asymmetric Synthesis with Organofluorines$422,066
R15 · FY2020 · GM · contact PI
Asymmetric Synthesis with Organofluorines and Terminal Ynamides$426,099
R15 · FY2017 · GM · contact PI
Synthesis of Chiral Organofluorines via Catalytic Asymmetric C-C Bond Formation w$337,287
R15 · FY2013 · GM · contact PI
Designing HTA therapy for drug resistant malaria$360,904
R01 · FY2009 · AI · contact PI
Designing HTA therapy for drug resistant malaria$360,904
R01 · FY2008 · AI · contact PI
Designing HTA therapy for drug resistant malaria$367,894
R01 · FY2007 · AI · contact PI
Designing HTA therapy for drug resistant malaria$378,882
R01 · FY2006 · AI · contact PI
Designing HTA therapy for drug resistant malaria$388,000
R01 · FY2005 · AI